Malaysia monitors QDENGA vaccine safety in 2,000 people
NCT ID NCT06388785
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tracks side effects and severe dengue cases in 2,000 people who already got the QDENGA dengue vaccine in Malaysia. No new vaccine is given—researchers simply collect health data from participants. The goal is to understand real-world safety and whether vaccinated people still need hospital care for severe dengue.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DENGUE FEVER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Universiti Malaya
Kuala Lumpur, Kuala Lumpur, 50603, Malaysia
-
Universiti Putra Malaysia
Serdang, Selangor, 43400, Malaysia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a dengue vaccine be both Cost-Effective and trusted? a thai study investigates
- Dengue vaccine booster put to the test: can it shield against all four virus types?
- Flu drug zanamivir tested against Dengue's deadliest complication
- AI toolkit aims to speed up epidemic response for diseases like COVID-19 and mpox
- Could a new vaccine shield infants from dengue?
- Ultrasound clues could predict dangerous dengue